Wait for a consolidation to take the fresh long positions as long as Nifty trades above the 12,030 mark. But any close below the prior bar low, will be a sign of weakening trend. Stocks in news: Adani Transmission, Wipro, Bharti Airtel, Adani Enterprises, BEML.

The bulls continued to march higher and recorded gains for the fourth consecutive day after RBI left policy rates unchanged but maintained its accommodative stance to boost growth. However, on candlestick pattern, there is a formation of ‘spinning top’ like candle and a V-shaped recovery formation of this pattern indicates profit booking.

Prestige Estates, the leading real-estates development company in India, informed on Thursday that they have raised Rs 900 crore through Qualified Institutional Placement (QIP).

On Thursday, the shares of Hind Rectifiers fell by around 17.39 per cent, due to heavy selling, after the company reported its results for the quarter ended December 2019.

Its consolidated revenue for the quarter Q3FY20 came in at Rs 2,582.74 crore, as against Rs 2,281.55 crore in the corresponding quarter last year, registering 13.2 per cent YoY increase. EBITDA for the quarter grew by 136.1 per cent YoY to Rs 408.29 crore, as against Rs 172.93 crore in the corresponding quarter last year, with a corresponding margin expansion of 823 bps.

Reserve Bank of India (RBI) held rates steady on Thursday, as it sought to support faltering growth and avoid stoking already high inflation levels.

PSP Projects announced on Thursday that it was in receipt of Letter of Authorisation (LOA) for work orders worth Rs 41.68 crore, excluding GST for an institutional and government project.

It is expected that 2020 might prove to be a turnaround year for small-cap stocks. In this anticipation, IDFC Mutual Fund has launched IDFC Emerging Businesses Fund, an open-ended equity scheme. Read on to find out whether is it worth subscribing or not.

Rites reported its third quarter result of FY20 today, in which, its revenue from operations increased by nearly 16 per cent, YoY to Rs 602.6 crore in the quarter.

Granules India’s wholly-owned foreign subsidiary-Granules Pharmaceuticals, Inc, had filed the Abbreviated New Drug Application (ANDA) for Colchicine tablets USP, 0.6 mg for which it has received US Food & Drug Administration (USFDA) approval.